Angel is a highly motivated, ambitious 10-year-old schoolgirl who grew up in Accra, Ghana, in a very poor family. 

Until two years ago, she lived with her mother, grandmother, aunts and uncles in a simple hut without access to running water or a toilet. As living conditions were too harsh and she had no friends her own age in Accra, Angel moved to the mountains to her grandmother's birthplace, where she now attends the local school. 

In addition to normal living expenses, costs for schooling must also be covered:

SCHOOLING

School fees                

School uniforms

School books

Sports clothing

Trainers

Clothing for desired profession: Becoming a medical Doctor

Food containers for daily school meals

Excursions

HEALTH

Malaria        Pharmacies only sell vitamins, neither the important differentiation tests nor selected medications.

Diarrhoea        Charcoal tablets

Worming treatments   

CHURCH ACTIVITIES

Excursions

Donations at the end of mass

SAVING FOR HIGHER EDUCATION

People can no longer cushion the inflation rate of over 100 % even with their income.  And they are also afraid that they will no longer be able to pay the rent for their flats.

Angel's mother was hit by a taxi when she was 8 years old through no fault of her own and woke up unconscious in hospital. No x-rays or other important tests were carried out, only painkillers. Painkillers were administered.

Since the SARS CoV-2 vaccination, she has been experiencing all known symptoms without warning. And this in anxiety-provoking forms.  Well known as SARS CoV-2 Syndrome

States of anxiety, tension and agitation

Autoimmune diseases

depression

Cardiovascular diseases

Respiratory complaints

Sleep disorders

pain

Visual complaints up to temporary blindness

Unfortunately, this is not yet an issue in Ghana. I therefore suggested to the CEO of the UGMC University of Ghana Medical Centre, via a nurse friend, that a similar institution be set up, modelled on the post-Covid outpatient clinic at Phillips University Marburg under the direction of Prof. Dr Bernhard Schieffer. I sent them a compact 30-page paper and offered them the prospect of personal contact and cooperation with Prof Schieffer. There has been no response to date.

The Vaxzevria vaccine produced by AstraZeneca, which made the headlines, was produced under licence by an Indian vaccine manufacturer and administered in Ghana. Of course, this producer has long been insolvent and cannot be held liable.